Dr Asit Arora
Sarita Vihar Delhi | Athena Defence Colony Delhi | Gurugram
GIST Cancer & Sarcoma

GIST Cancer & Sarcoma: Understanding These Rare Tumors and Modern Treatment Options

Gastrointestinal stromal tumors (GISTs) are uncommon tumors that develop in the digestive system, most frequently in the stomach or small intestine. They belong to a group of tumors known as sarcomas, which arise from connective, supportive, or soft tissues of the body.

Although GISTs can sometimes grow without obvious symptoms, early evaluation and accurate diagnosis are important for determining the most appropriate treatment. Advances in imaging, molecular testing, targeted medicines, and minimally invasive surgery have significantly improved the management of these tumors.

What Is GIST Cancer?

GIST, or Gastrointestinal Stromal Tumor, develops from specialized cells in the gastrointestinal tract called interstitial cells of Cajal (ICC) or related precursor cells. These cells help regulate movement through the digestive tract.

GISTs can occur anywhere along the gastrointestinal tract, but they are most commonly found in:

  • Stomach
  • Small intestine
  • Esophagus
  • Colon and rectum
  • Other areas of the gastrointestinal tract

Some GISTs are small and may be discovered incidentally during investigations for another condition, while larger or more aggressive tumors may cause noticeable symptoms.

What Is Sarcoma?

Sarcoma is a broad term for cancers that develop from connective and supporting tissues, including muscle, fat, blood vessels, nerves, bone, and other soft tissues.

GIST is considered a type of soft-tissue sarcoma, but it has unique biological and molecular characteristics. This distinction is important because GISTs often respond to specific targeted therapies that are different from conventional chemotherapy used for many other cancers.

Symptoms of GIST

Symptoms can vary depending on the size and location of the tumor. Possible symptoms include:

  • Abdominal pain or discomfort
  • A feeling of fullness after eating
  • Gastrointestinal bleeding
  • Blood in the stool or black, tarry stools
  • Nausea or vomiting
  • Loss of appetite
  • Unexplained weight loss
  • Fatigue or anemia
  • An abdominal lump in some cases

Some GISTs may cause no symptoms at all and are detected during imaging, endoscopy, or surgery performed for another reason.

How Is GIST Diagnosed?

Diagnosis usually involves a combination of clinical evaluation, imaging, endoscopy, and tissue testing.

Imaging Tests

CT scans are commonly used to assess the location and size of a tumor and to determine whether it has spread to other parts of the body. MRI or other imaging tests may also be recommended in selected cases.

Endoscopy

For tumors involving the stomach or other accessible parts of the gastrointestinal tract, endoscopy can help identify abnormal growths. Endoscopic ultrasound may provide additional information about the layers of the gastrointestinal wall involved.

Biopsy and Pathology

A tissue sample may be examined under a microscope to confirm the diagnosis. Immunohistochemical testing can help distinguish GIST from other gastrointestinal tumors.

Molecular Testing

Molecular analysis can identify genetic changes such as KIT or PDGFRA mutations. These findings can be important in determining treatment because certain targeted medicines work particularly well against tumors carrying specific molecular alterations.

Treatment Options for GIST

Treatment depends on factors such as tumor size, location, risk of recurrence, molecular characteristics, and whether the disease has spread.

Surgery

For localized GISTs that can be safely removed, surgery is an important treatment option. The goal is generally to remove the tumor completely while preserving as much normal gastrointestinal function as possible.

In selected patients, laparoscopic or robotic surgery may be considered depending on the tumor's location, size, relationship with surrounding structures, and the surgeon's assessment.

Targeted Therapy

GISTs are different from many other cancers because targeted medicines can play a major role in treatment.

Imatinib is commonly used for many GISTs, particularly those with sensitive KIT or PDGFRA mutations. Targeted therapy may be used before surgery in selected cases to reduce tumor size or after surgery when there is a significant risk of recurrence.

Other targeted therapies may be considered when a tumor does not respond to initial treatment or develops resistance.

Treatment for Advanced GIST

When GIST has spread to other organs or cannot be completely removed surgically, treatment may involve targeted systemic therapy, surgery in carefully selected situations, or other specialized approaches.

Management of advanced GIST often requires ongoing assessment using imaging and molecular information.

GIST and Sarcoma: Why Specialized Care Matters

GIST and other sarcomas can be complex to diagnose and treat because they include many different tumor subtypes. Their treatment may require coordination between surgical oncology, medical oncology, radiology, pathology, and other specialists.

A multidisciplinary approach helps determine whether surgery, targeted therapy, surveillance, or a combination of treatments is most appropriate.

Can GIST Come Back After Treatment?

Some GISTs have a low risk of recurrence, while others have a higher risk depending on factors such as tumor size, location, mitotic rate, tumor rupture, and molecular characteristics.

Patients who undergo treatment may therefore require regular follow-up with clinical evaluation and imaging. The follow-up schedule is individualized according to the risk of recurrence and treatment history.

Frequently Asked Questions

GIST is a type of tumor that can behave as a cancer, with some tumors having a higher risk of spreading or recurring than others.

Surgery is an important treatment for many localized GISTs when complete removal is considered feasible and safe.

Conventional chemotherapy generally has a limited role in GIST. Targeted therapies are often much more important because they specifically act on molecular pathways involved in many GISTs.

Higher-risk GISTs can spread, most commonly to the liver and the peritoneal cavity. The risk depends on several tumor characteristics.

Robotic surgery may be appropriate for selected patients depending on the tumor's size, location, anatomy, and the feasibility of achieving safe and complete tumor removal. The surgical approach should be individualized for each patient.